Abstract
Rates of abdominopelvic surgery, with a particular focus on gallbladder procedures, were measured in patients with irritable bowel syndrome (IBS) (n= 108,936) and compared with those in a general population sample (n= 223,082). The patient sample was selected from persons who were members of a managed care organization during the years 1995–2000. Medical records from a randomly selected subset of IBS patients were reviewed to confirm the diagnosis. Crude and standardized rates and adjusted rate ratios for surgery were calculated. The incidence of abdominopelvic surgery, excluding gallbladder procedures, was 87% higher in patients with IBS than that for the general population. The incidence of gallbladder surgery was threefold higher in IBS patients than the general population. Patients with IBS have an increased risk for abdominopelvic and gallbladder surgery and, thus, an associated risk for experiencing morbidity and mortality associated with these surgical procedures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Talley NJ, Zinsmeister AR, Melton LJ 3rd: Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 142:76–83, 1995
Horwitz BJ, Fisher RS: The irritable bowel syndrome. N Engl J Med 344:1846–1850, 2001
Kennedy TM, Jones RH: Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population. Br J Surg 87:1658–1663, 2000
Hasler WL, Schoenfeld P: Systematic review: Abdominal and pelvic surgery in patients with irritable bowel syndrome. Aliment Pharmacol Ther 17:997–1005, 2003
Novartis: Zelnorm [package insert]. East Hanover, NJ, Novartis, 2002
Fidelholtz J, Smith W, Rawls J, et al.: Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms. Am J Gastroenterol 97:1176–1181, 2002
Kellow J, Lee OY, Chang FY, et al.: An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 52:671–676, 2003
Muller-Lissner SA, Fumagalli I, Bardhan KD, et al.: Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 15:1655–1666, 2001
Novick J, Miner P, Krause R, et al.: A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 16:1877–1888, 2002
Lanza LL, Dreyer NA, Schulz NJ, Walker AM: Use of insurance claims in epidemiologic research: Identification of peptic ulcers, GI bleeding, pancreatitis, hepatitis and renal disease. Pharmacoepidemiol Drug Saf 4:239–248, 1995
Quam L, Ellis LB, Venus P, Clouse J, Taylor CG, Leatherman S: Using claims data for epidemiologic research. The concordance of claims-based criteria with the medical record and patient survey for identifying a hypertensive population. Med Care 31:498–507, 1993
Medicode: International Classification of Diseases, 9th Revision, Clinical Modification. Salt Lake City, UT: Medicode, 2001
American Society of Health-System Pharmacists: AHFS Drug Handbook. Bethesda, Md. Philadelphia, PA, American Society of Health-System Pharmacists, Lippincott Williams & Wilkins, 2002, pp ix, 1349
Rothman KJ: Epidemiology: An Introduction. New York: Oxford University Press, 2002, pp viii, 223
Rothman KJ, Boice JD: Epidemiologic analysis with a programmable calculator. Bethesda, Md. Washington, DC: U.S. Department of Health Education and Welfare, Public Health Service, National Institutes of Health, 1979, pp vii, 142
Stokes ME, Davis CS, Koch GG: Categorical Data Analysis Using the SAS System. Cary, NC, SAS Institute, 2000, viii, p 626
Talley NJ: Irritable bowel syndrome: definition, diagnosis and epidemiology. Baillieres Best Pract Res Clin Gastroenterol 13:371–384, 1999
Longstreth GF, Yao JF: Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 126:1665–1673, 2004
Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol 97:S1–S5, 2002
Cole JA, Cook SF, Sands BE, Ajene AN, Miller DP, Walker AM: Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol 99:486–491, 2004
Author information
Authors and Affiliations
Corresponding author
Additional information
J. Alexander Cole participated in the design of the study and its coordination. Jason Yeaw managed the databases and conducted the analysis. Jennifer Cutone provided oversight for the medical record abstraction. Braden Kuo classified the abstracted medical records. Zhiping Huang contributed to the manuscript review and revision. David Earnest participated in the design of the study and the development of the manuscript. Alexander Walker conceived the study and participated in the study design. All authors read and approved the final manuscript.
Rights and permissions
About this article
Cite this article
Cole, J.A., Yeaw, J.M., Cutone, J.A. et al. The Incidence of Abdominal and Pelvic Surgery Among Patients with Irritable Bowel Syndrome. Dig Dis Sci 50, 2268–2275 (2005). https://doi.org/10.1007/s10620-005-3047-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-3047-1